217 related articles for article (PubMed ID: 1154379)
1. Glucagon-induced insulin secretion in normal diabetic subjects.
Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
[TBL] [Abstract][Full Text] [Related]
2. Insulin response to glucagon with or without tolbutamide in normal and diabetic subjects.
Chiba M; Ohneda A; Sakai T; Goto Y
Tohoku J Exp Med; 1982 Feb; 136(2):169-75. PubMed ID: 7041329
[TBL] [Abstract][Full Text] [Related]
3. Improvement in insulin secretion in diabetes after diazoxide.
Greenwood RH; Mahler RF; Hales CN
Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
[TBL] [Abstract][Full Text] [Related]
4. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
Adibi SA; Morse EL; Amin PM
J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
[TBL] [Abstract][Full Text] [Related]
5. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
6. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
Barnes AJ; Garbien KJ; Crowley MF; Bloom A
Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
[No Abstract] [Full Text] [Related]
7. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
Castells S; Avruskin T; Reddy CM; Hashemi SE
Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].
Berchtold P; Büber V; Meier V; Felber JP; Keiser G
Diabetologia; 1971 Apr; 7(2):77-81. PubMed ID: 5581543
[No Abstract] [Full Text] [Related]
9. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
Bagdade JD; Bierman EL; Porte D
Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
[No Abstract] [Full Text] [Related]
10. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
[TBL] [Abstract][Full Text] [Related]
11. Plasma insulin disturbances in primary hyperparathyroidism.
Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
[TBL] [Abstract][Full Text] [Related]
12. Acute insulin response to glucagon, tolbutamide, and glucose in non-insulin-dependent diabetes of the young.
Naidoo C; Jialal I; Suleman A; Rajput MC; Joubert SM
Diabetes Care; 1986; 9(1):57-60. PubMed ID: 3512209
[TBL] [Abstract][Full Text] [Related]
13. Insulin response to glucose or glucagon in subclinical diabetes previously injected with tolbutamide.
Ohneda A; Watanabe K; Maruhama Y; Itabashi H; Horigome K
Tohoku J Exp Med; 1977 Jan; 121(1):27-32. PubMed ID: 835136
[TBL] [Abstract][Full Text] [Related]
14. Insulin and glucagon secretion in BB wistar rats with impaired glucose tolerance.
Nakhooda AF; Poussier P; Marliss EB
Diabetologia; 1983 Jan; 24(1):58-62. PubMed ID: 6337908
[TBL] [Abstract][Full Text] [Related]
15. [Blood insulin and diabetes. I. Method of study--normal subjects--diabetic disease].
Duprey J; Lubetzki J
Pathol Biol (Paris); 1971 Mar; 19(5):311-31. PubMed ID: 4929994
[No Abstract] [Full Text] [Related]
16. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
17. [Types of insulin secretion in diabetes mellitus].
Verlohren HJ; Vrahimis J; Lohmann D
Dtsch Z Verdau Stoffwechselkr; 1975; 35(4):183-90. PubMed ID: 1227812
[No Abstract] [Full Text] [Related]
18. The inexhaustible beta cell.
Vinik AI; Kalk WJ; Botha JL; Jackson WP; Blake KC
Diabetes; 1976 Jan; 25(1):11-5. PubMed ID: 1107093
[TBL] [Abstract][Full Text] [Related]
19. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
[TBL] [Abstract][Full Text] [Related]
20. [Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
Melani F; Lawecki J; Bartelt KM; Pfeiffer EF
Diabetologia; 1967 Oct; 3(5):422-6. PubMed ID: 5620801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
